Neuromuscular transmission is not impaired in axonal Guillain--Barré syndrome.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 21071752.
- Also identified by DOI 10.1136/jnnp.2010.210708.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Previous studies have shown that anti-GQ1b antibodies induce massive neuromuscular blocking. If anti-GM1 and -GD1a antibodies have similar effects on the neuromuscular junction (NMJ) in human limb muscles, this may explain selective motor involvement in axonal Guillain--Barré syndrome (GBS). Axonal-stimulating single-fibre electromyography was performed in the extensor digitorum communis muscle of 23 patients with GBS, including 13 with the axonal form whose sera had a high titre of serum IgG anti-GM1 or -GD1a antibodies. All patients with axonal or demyelinating GBS showed normal or near-normal jitter, and no blocking. In both axonal and demyelinating GBS, neuromuscular transmission is not impaired. Our results failed to support the hypothesis that anti-GM1 or -GD1a antibody affects the NMJ. In GBS, impulse transmission is presumably impaired in the motor nerve terminal axons proximal to the NMJ.
Medical subject headings
- Axons
- Guillain-Barre Syndrome
- Neuromuscular Junction
- Synaptic Transmission